Products for Research Use Only

LOC14

CAT: 1410-M20192-01Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:1410-M20192-01Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
LOC14 to be the most potent PDI inhibitor reported to date (EC50 : 500 nM) .
CAS Number
877963-94-5
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
317.4
Molecular Formula
C16H19N3O2S
Notes
Research use only, not for human use.
Receptor
PDI

Chemical Information

2-[[4-(Cyclopropanecarbonyl)piperazin-1-yl]methyl]-1,2-benzothiazol-3-one
CAS Number877963-94-5
PubChem CID9117962
IUPAC Name2-[[4-(cyclopropanecarbonyl)piperazin-1-yl]methyl]-1,2-benzothiazol-3-one
Molecular FormulaC16H19N3O2S
Molecular Weight317.4
XLogP1.3
Topological Polar Surface Area69.2
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count4
Rotatable Bond Count3
Heavy Atom Count22
Formal Charge0
Complexity460
SMILES
C1CC1C(=O)N2CCN(CC2)CN3C(=O)C4=CC=CC=C4S3
InChI
InChI=1S/C16H19N3O2S/c20-15(12-5-6-12)18-9-7-17(8-10-18)11-19-16(21)13-3-1-2-4-14(13)22-19/h1-4,12H,5-11H2
InChIKey
YVBSNHLFRIVWFQ-UHFFFAOYSA-N
Chemical Structure
2D Structure
2D structure of 2-[[4-(Cyclopropanecarbonyl)piperazin-1-yl]methyl]-1,2-benzothiazol-3-one
CAS: 877963-94-5
CID: 9117962
Formula: C16H19N3O2S
MW: 317.4
Interactive 3D Structure
Loading 3D structure...
Computed Properties
PropertyValue
Molecular Weight317.4
XLogP31.3
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count4
Rotatable Bond Count3
Exact Mass317.11979803
Monoisotopic Mass317.11979803
Topological Polar Surface Area69.2 Ų
Heavy Atom Count22
Formal Charge0
Complexity460
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count1
Compound Is CanonicalizedYes